Abits
ABTS
FRMO CORP
FRMO
Mawson Infrastructure
MIGI
Ebang International
EBON
BIT Mining
BTCM
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.